-
BTIG Moves To Neutral On DexCom, But Says Shares Are Not Overvalued
Wednesday, September 14, 2016 - 10:01am | 346Read More...BTIG cut DexCom, Inc. (NASDAQ: DXCM) to Neutral from Buy, as the shares have reached its $92 price target. The firm added that the company must focus on profitability "for a sustained run well above $100." "While we do not think shares are overvalued and could argue for a bit more upside as revenue...
-
Changes To Starbucks Rewards Program Could Affect Store Traffic
Monday, September 12, 2016 - 8:40am | 260Read More...Starbucks Corporation’s (NASDAQ: SBUX) shift to the new Rewards program could impact traffic much more than was earlier estimated, BTIG’s Peter Saleh said in a report. He maintained a Buy rating on the company, with a price target of $64. Starbucks changed its Rewards program from...
-
Reports Of Private Equity Interest In VeriFone Systems Came As No Surprise To BTIG Analysts
Friday, September 9, 2016 - 12:12pm | 390Read More...BTIG said it is not surprised by recent reports of private equity interest in VeriFone Systems Inc (NYSE: PAY), as the company's strong free cash flow and attractive valuation make it an "interesting" takeover target. Analyst Mark Palmer, who started coverage of the stock with a Buy rating and...
-
Tractor Supply Hit With A Slew Of Sell-Side Downgrades As Guidance Disappoints
Thursday, September 8, 2016 - 3:00pm | 332Read More...Tractor Supply Company (NASDAQ: TSCO) shares hit a 52-week low of $69.27 on Thursday following multiple headwinds hurting investor sentiment. The company likely initiated the first move downward with the announcement of its full-year earnings and revenue outlook reduction. Accordingly, the revised...
-
BTIG Downgrades Tractor Supply Following Outlook On 'Sustained Weakness'; Stock Topples
Thursday, September 8, 2016 - 9:11am | 381Read More...Close on the heels of Tractor Supply Company (NASDAQ: TSCO) reducing its full-year outlook, BTIG downgraded the stock from Buy to Neutral, citing "sustained weakness." Following the downbeat guidance and downgrade, the stock tanked more than 14 percent in pre-market trading. In the last four...
-
BTIG Sees Another Bidder For Cepheid 'Unlikely'
Wednesday, September 7, 2016 - 11:22am | 310Read More...BTIG sees competing bids for Cepheid (NASDAQ: CPHD) unlikely following its deal to be acquired by Danaher Corporation (NYSE: DHR) for $53 a share in cash. "Though the purchase price is essentially in line with CPHD's 52-week high ($53.19), we think its implied multiple of ~6x EV/NTM Sales is fair...
-
Twitter Is Still Basically What It Was In 2008
Wednesday, September 7, 2016 - 7:41am | 365Read More...Shares of Twitter Inc (NYSE: TWTR) have gained 8 percent since August 30, following Co-Founder and Director Evan Williams’ comments related to a possible sale of the company. The platform hasn't changed much since 2008 and Twitter still needs to figure out how to expand its user base,...
-
BTIG: Salesforce Weakness Partially Due To Seasonality
Thursday, September 1, 2016 - 7:58am | 314Read More...Although salesforce.com, inc. (NYSE: CRM) reported broadly in-line Q2 results, there is likely to be investor concern regarding “the full implications of the underwhelming billings performance and guidance,” BTIG’s Joel P. Fishbein said in a report. He maintained a Buy rating on...
-
H&R Block's Q1 Is A Reminder Of Operational Struggles
Wednesday, August 31, 2016 - 9:44am | 352Read More...BTIG’s Mark Palmer mentioned that buyout rumors emerged once again regarding H & R Block Inc (NYSE: HRB) following the modest rise in the share price. Palmer reiterated a Neutral rating on the company. Operational Struggles The analyst pointed out the Q1:17 results, released by H&R...
-
Sell Juno Therapeutics: BTIG Says It's Trailing The Competition
Wednesday, August 31, 2016 - 9:19am | 307Read More...BTIG’s Dane Leone believes that while Juno Therapeutics Inc (NASDAQ: JUNO) has the most robust CD19 CAR T datasets among its competitors, it is trailing in terms of timelines for regulatory approval and commercialization. Leone initiated coverage of the company with a Sell rating and price...
-
BTIG Is 'Generally Skeptical' On Kite Pharma Expectations
Wednesday, August 31, 2016 - 9:17am | 429Read More...BTIG has started coverage of Kite Pharma Inc (NASDAQ: KITE) with a Neutral rating, as it is skeptical over current investor expectations for the CD19 CAR T market, given the limited datasets and potential competition from CD19 bi-specific antibodies. Kite is pursuing Chimeric Antigen Receptor T-...
-
Palo Alto Estimates Expected To 'Tick Up' At BTIG
Wednesday, August 31, 2016 - 7:27am | 316Read More...Palo Alto Networks Inc (NYSE: PANW) reported its Q4 results broadly in-line with expectations, while the guidance for FY17 could prove conservative, BTIG’s Joel P. Fishbein said in a report. He maintained a Buy rating on the company, with a price target of $210. While Palo Alto’s...
-
BTIG Downgrades Square As Shares Are Now Fairly Valued
Monday, August 29, 2016 - 7:26am | 328Read More...Shares of Square Inc (NYSE: SQ) have surged almost 40 percent since June 27. BTIG’s Mark Palmer downgraded the rating on the company from Buy to Neutral, while removing the price target of $12, at which the shares are currently trading. Square’s shares had dipped below the $9 mark,...
-
BTIG Says Workday 'Working It,' Raises Price Target
Thursday, August 25, 2016 - 8:27am | 277Read More...Workday Inc (NYSE: WDAY) reported healthy quarterly results, with both billings and revenues beating Street expectations. Large customer wins and a healthy pipeline support the assumption of the company being able to sustain medium term growth of more than 30 percent, BTIG’s Joel P....
-
Nimble Storage May Be Regaining Its Footing On The Path To Growth
Wednesday, August 24, 2016 - 10:53am | 325Read More...Nimble Storage Inc (NYSE: NMBL) reported its Q2 results ahead of the “modest” expectations, with product revenue in only the mid-teens and opex growth in the 30s. BTIG’s Edward Parker maintained a Neutral rating on the company. Regaining Footing “Nimble is making...
